Documents filed in a federal lawsuit against Parke Davis shed more light on allegations that the drug manufacturer marketed the anti-seizure drug Neurontin for various unauthorized uses. NPR's Snigdha Prakash reports.
Copyright 2002 NPR
Snigdha Prakash
Pieces by National Desk reporter Snigdha Prakash can be heard on NPR's All Things Considered and Morning Edition. The majority of Snigdha's past reports have focused on topics related to entrepreneurship, business, banking and the economy.